FutureChem Co.,Ltd (220100.KQ)

KRW 25200.0

(0.0%)

Revenue Summary of FutureChem Co.,Ltd

  • FutureChem Co.,Ltd's latest annual revenue in 2023 was 13.96 Billion KRW , up 11.09% from previous year.
  • FutureChem Co.,Ltd's latest quarterly revenue in 2024 Q1 was 3.43 Billion KRW , down -26.55% from previous quarter.
  • FutureChem Co.,Ltd reported a annual revenue of 12.57 Billion KRW in annual revenue 2022, up 6.39% from previous year.
  • FutureChem Co.,Ltd reported a annual revenue of 11.81 Billion KRW in annual revenue 2021, up 7.31% from previous year.
  • FutureChem Co.,Ltd reported a quarterly revenue of 3.43 Billion KRW for 2024 Q2, down -0.11% from previous quarter.
  • FutureChem Co.,Ltd reported a quarterly revenue of 13.96 Billion KRW for 2023 FY, up 11.09% from previous quarter.

Annual Revenue Chart of FutureChem Co.,Ltd (2023 - 2016)

Historical Annual Revenue of FutureChem Co.,Ltd (2023 - 2016)

Year Revenue Revenue Growth
2023 13.96 Billion KRW 11.09%
2022 12.57 Billion KRW 6.39%
2021 11.81 Billion KRW 7.31%
2020 11.01 Billion KRW 34.86%
2019 8.16 Billion KRW 44.91%
2018 5.63 Billion KRW 87.95%
2017 2.99 Billion KRW 84.48%
2016 1.62 Billion KRW 0.0%

Peer Revenue Comparison of FutureChem Co.,Ltd

Name Revenue Revenue Difference
HLB Pharmaceutical Co., Ltd 135.95 Billion KRW 89.726%
CMG Pharmaceutical Co., Ltd. 93.9 Billion KRW 85.126%
Celltrion Pharm, Inc. 388.79 Billion KRW 96.407%
Huons Global Co., Ltd. 758.37 Billion KRW 98.158%
DongKook Pharmaceutical Co., Ltd. 730.99 Billion KRW 98.089%
Enzychem Lifesciences Corporation 76.03 Billion KRW 81.63%
Humedix Co., Ltd. 152.27 Billion KRW 90.827%
Boditech Med Inc. 134.21 Billion KRW 89.593%
EuBiologics Co., Ltd. 69.36 Billion KRW 79.863%
Huons Co., Ltd. 552 Billion KRW 97.47%
BNC Korea Co., Ltd. 80.99 Billion KRW 82.755%
AptaBio Therapeutics Inc. 323.86 Million KRW -4212.862%